A Single-Center Pilot Study to Assess Macular Function

This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Macular Degeneration Eye Diseases Retinal Degeneration Retinal Diseases

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Andover, Massachusetts, 01810, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
Subjects with early non-exudative age-related macular degeneration (AMD cohort)

Exclusion criteria

Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

Sponsors and collaborators

Lead sponsor

ORA, Inc.

Industry

Registry information

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Sep 17, 2010
Registry last updated: Feb 14, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed